Life Sciences

As the close of 2011 nears, companies around the globe are firming up their business plans for the coming year in a very uncertain environment. The Euro Zone crisis and slower economic growth in the world’s biggest economies has dampened some of the optimism that was the hallmark of the first part of this year.

SpenglerFox recently organized a Global Conference call on Russian Investments hosted by expert speaker, Robert Rosen with over 24 senior executives in attendance. The discussion provided better understanding into the Russian market by looking at the implications of the recent announcements to both the political and economic landscape. Rosen shared his insights on the factors that promote Russia as a profit market for global investors as well as the forecasts that influence investment decisions.

Central and Eastern Europe is one of the very few markets within the healthcare and pharmaceutical industry that continues to grow. Despite the fact that the majority of the Life Sciences industry markets are experiencing major workforce cuts due to a diminishing industry pipeline the CEE market continues to deliver steady growth. Consequently, this market has become a major focus of development for Life Sciences companies and specialist recruitment is as important as ever. However recent mergers have also led to a surplus of specialists within the industry.

Read more ...